Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?

Goldstein O, Gana-Weisz M, Cohen-Avinoam D, Shiner T, Thaler A, Cedarbaum JM, John S, Lalioti M, Gurevich T, Bar-Shira A, Mirelman A, Giladi N, Orr-Urtreger A.

Mol Genet Metab. 2019 Dec;128(4):470-475. doi: 10.1016/j.ymgme.2019.10.001. Epub 2019 Oct 13.

PMID:
31662221
2.

Distinguishing Dementia With Lewy Bodies From Alzheimer Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews?

Bregman N, Kavé G, Mirelman A, Thaler A, Gana Weisz M, Bar-Shira A, Orr-Urtreger A, Giladi N, Shiner T.

Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):279-281. doi: 10.1097/WAD.0000000000000283.

PMID:
30640255
3.

Dissociation in awareness of memory and language decline in Alzheimer's disease.

Bregman N, Kavé G, Shiner T, Biran I; Alzheimer's Disease Neuroimaging Initiative.

Int J Geriatr Psychiatry. 2019 Apr;34(4):548-554. doi: 10.1002/gps.5049. Epub 2018 Dec 21.

PMID:
30548691
4.

Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.

Thaler A, Kliper E, Maidan I, Herman T, Rosenberg-Katz K, Bregman N, Gurevich T, Shiner T, Hausdorff JM, Orr-Urtreger A, Giladi N, Mirelman A.

Brain Topogr. 2018 Nov;31(6):1029-1036. doi: 10.1007/s10548-018-0653-8. Epub 2018 May 30.

PMID:
29846835
5.

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.

Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, Gan-Or Z, Bar-Shira A, Gana-Weisz M, Orr-Urtreger A, Giladi N, Mirelman A.

Parkinsonism Relat Disord. 2018 Oct;55:45-49. doi: 10.1016/j.parkreldis.2018.05.009. Epub 2018 May 17.

PMID:
29784561
6.

A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.

Thaler A, Gurevich T, Bar Shira A, Gana Weisz M, Ash E, Shiner T, Orr-Urtreger A, Giladi N, Mirelman A.

Parkinsonism Relat Disord. 2017 Mar;36:47-51. doi: 10.1016/j.parkreldis.2016.12.014. Epub 2016 Dec 16.

PMID:
28012950
7.

High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.

Shiner T, Mirelman A, Gana Weisz M, Bar-Shira A, Ash E, Cialic R, Nevler N, Gurevich T, Bregman N, Orr-Urtreger A, Giladi N.

JAMA Neurol. 2016 Dec 1;73(12):1448-1453. doi: 10.1001/jamaneurol.2016.1593.

PMID:
27723861
8.

Deep brain stimulation of the subthalamic nucleus modulates sensitivity to decision outcome value in Parkinson's disease.

Seymour B, Barbe M, Dayan P, Shiner T, Dolan R, Fink GR.

Sci Rep. 2016 Sep 14;6:32509. doi: 10.1038/srep32509.

9.

Dopamine, Salience, and Response Set Shifting in Prefrontal Cortex.

Shiner T, Symmonds M, Guitart-Masip M, Fleming SM, Friston KJ, Dolan RJ.

Cereb Cortex. 2015 Oct;25(10):3629-39. doi: 10.1093/cercor/bhu210. Epub 2014 Sep 21.

10.

Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation.

Sheerin UM, Stamelou M, Charlesworth G, Shiner T, Spacey S, Valente EM, Wood NW, Bhatia KP.

J Neurol. 2013 Feb;260(2):656-60. doi: 10.1007/s00415-012-6747-4. Epub 2012 Nov 24. No abstract available.

11.

The effect of motivation on movement: a study of bradykinesia in Parkinson's disease.

Shiner T, Seymour B, Symmonds M, Dayan P, Bhatia KP, Dolan RJ.

PLoS One. 2012;7(10):e47138. doi: 10.1371/journal.pone.0047138. Epub 2012 Oct 15.

12.

Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease.

Shiner T, Seymour B, Wunderlich K, Hill C, Bhatia KP, Dayan P, Dolan RJ.

Brain. 2012 Jun;135(Pt 6):1871-83. doi: 10.1093/brain/aws083. Epub 2012 Apr 15.

13.

Dopamine, affordance and active inference.

Friston KJ, Shiner T, FitzGerald T, Galea JM, Adams R, Brown H, Dolan RJ, Moran R, Stephan KE, Bestmann S.

PLoS Comput Biol. 2012 Jan;8(1):e1002327. doi: 10.1371/journal.pcbi.1002327. Epub 2012 Jan 5.

14.

Experience and choice shape expected aversive outcomes.

Sharot T, Shiner T, Dolan RJ.

J Neurosci. 2010 Jul 7;30(27):9209-15. doi: 10.1523/JNEUROSCI.4770-09.2010.

15.

Dopamine, time, and impulsivity in humans.

Pine A, Shiner T, Seymour B, Dolan RJ.

J Neurosci. 2010 Jun 30;30(26):8888-96. doi: 10.1523/JNEUROSCI.6028-09.2010.

16.

Dopamine enhances expectation of pleasure in humans.

Sharot T, Shiner T, Brown AC, Fan J, Dolan RJ.

Curr Biol. 2009 Dec 29;19(24):2077-80. doi: 10.1016/j.cub.2009.10.025. Epub 2009 Nov 12.

17.

Pneumonia: are we putting the CURB score into practice?

Owen D, Shiner T, Sivakumar R, Dent R, Hilton C.

BMJ. 2006 May 20;332(7551):1213. No abstract available.

18.

The financial cost of optimising blood pressure control.

Shiner T, Simons L, Parkinson H, Khanbhai A, Karthikeyan VJ, Nandhara G, Beevers DG.

J Hum Hypertens. 2005 Jan;19(1):83-4. Erratum in: J Hum Hypertens. 2005 Oct;19(10):849. Nandhara, G [added]; Karthikeyen, VJ [added]. J Hum Hypertens. 2006 May;20(5):382. Karthikeyen, VJ [corrected to Karthikeyan, VJ].

PMID:
15372065
19.

Radiofrequency source of potassium resonance radiation for use in kilogauss magnetic fields.

Berdowski W, Shiner T, Krause L.

Appl Opt. 1967 Oct 1;6(10):1683-6. doi: 10.1364/AO.6.001683.

PMID:
20062288

Supplemental Content

Loading ...
Support Center